Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Journal of Virology Vol. 80; no. 5; pp. 2463 - 2471 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.03.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | The innate antiviral factor TRIM5 alpha restricts the replication of some retroviruses through its interaction with the viral capsid protein, leading to abortive infection. While overexpression of human TRIM5 alpha results in modest restriction of human immunodeficiency virus type 1 (HIV-1), this inhibition is insufficient to block productive infection of human cells. We hypothesized that polymorphisms within TRIM5 may result in increased restriction of HIV-1 infection. We sequenced the TRIM5 gene (excluding exon 5) and the 4.8-kb 5' putative regulatory region in genomic DNA from 110 HIV-1-infected subjects and 96 exposed seronegative persons, along with targeted gene sequencing in a further 30 HIV-1-infected individuals. Forty-eight single nucleotide polymorphisms (SNPs), including 20 with allele frequencies of >1.0%, were identified. Among these were two synonymous and eight nonsynonymous coding polymorphisms. We observed no association between TRIM5 polymorphism in HIV-1-infected subjects and their set-point viral load after acute infection, although one TRIM5 haplotype was weakly associated with more rapid CD4 super(+) T-cell loss. Importantly, a TRIM5 haplotype containing the nonsynonymous SNP R136Q showed increased frequency among HIV-1-infected subjects relative to exposed seronegative persons, with an odds ratio of 5.49 (95% confidence interval = 1.83 to 16.45; P = 0.002). Nonetheless, we observed no effect of individual TRIM5 alpha nonsynonymous mutations on the in vitro HIV-1 susceptibility of CD4 super(+) T cells. Therefore, any effect of TRIM5 alpha polymorphism on HIV-1 infection in primary lymphocytes may depend on combinations of SNPs or on DNA sequences in linkage disequilibrium with the TRIM5 alpha coding sequence. The innate antiviral factor TRIM5α restricts the replication of some retroviruses through its interaction with the viral capsid protein, leading to abortive infection. While overexpression of human TRIM5α results in modest restriction of human immunodeficiency virus type 1 (HIV-1), this inhibition is insufficient to block productive infection of human cells. We hypothesized that polymorphisms within TRIM5 may result in increased restriction of HIV-1 infection. We sequenced the TRIM5 gene (excluding exon 5) and the 4.8-kb 5′ putative regulatory region in genomic DNA from 110 HIV-1-infected subjects and 96 exposed seronegative persons, along with targeted gene sequencing in a further 30 HIV-1-infected individuals. Forty-eight single nucleotide polymorphisms (SNPs), including 20 with allele frequencies of >1.0%, were identified. Among these were two synonymous and eight nonsynonymous coding polymorphisms. We observed no association between TRIM5 polymorphism in HIV-1-infected subjects and their set-point viral load after acute infection, although one TRIM5 haplotype was weakly associated with more rapid CD4 + T-cell loss. Importantly, a TRIM5 haplotype containing the nonsynonymous SNP R136Q showed increased frequency among HIV-1-infected subjects relative to exposed seronegative persons, with an odds ratio of 5.49 (95% confidence interval = 1.83 to 16.45; P = 0.002). Nonetheless, we observed no effect of individual TRIM5α nonsynonymous mutations on the in vitro HIV-1 susceptibility of CD4 + T cells. Therefore, any effect of TRIM5α polymorphism on HIV-1 infection in primary lymphocytes may depend on combinations of SNPs or on DNA sequences in linkage disequilibrium with the TRIM5α coding sequence. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI |
Author | John Bui M. Juliana McElrath Shuying Sue Li Quyen Vu Devon Livingston-Rosanoff Emily C. Speelmon Daniel E. Geraghty Lue Ping Zhao |
AuthorAffiliation | Medical Scientist Training Program, 1 Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, 2 Clinical Research, 3 Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington, 4 Departments of Medicine, 5 Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington 6 |
AuthorAffiliation_xml | – name: Medical Scientist Training Program, 1 Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, 2 Clinical Research, 3 Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington, 4 Departments of Medicine, 5 Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington 6 |
Author_xml | – sequence: 1 givenname: Emily C. surname: Speelmon fullname: Speelmon, Emily C. organization: Medical Scientist Training Program, Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, Clinical Research – sequence: 2 givenname: Devon surname: Livingston-Rosanoff fullname: Livingston-Rosanoff, Devon organization: Clinical Research – sequence: 3 givenname: Shuying Sue surname: Li fullname: Li, Shuying Sue organization: Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington – sequence: 4 givenname: Quyen surname: Vu fullname: Vu, Quyen organization: Clinical Research – sequence: 5 givenname: John surname: Bui fullname: Bui, John organization: Clinical Research – sequence: 6 givenname: Daniel E. surname: Geraghty fullname: Geraghty, Daniel E. organization: Clinical Research – sequence: 7 givenname: Lue Ping surname: Zhao fullname: Zhao, Lue Ping organization: Public Health Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, Washington – sequence: 8 givenname: M. Juliana surname: McElrath fullname: McElrath, M. Juliana organization: Clinical Research, Departments of Medicine, Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17511706$$DView record in Pascal Francis |
BookMark | eNqNkd1uFCEYhompsdvqNYgHejYjzMAAB5psGtuOqTFp1sYzwjLQpZmBFZht9rK8Ea_J2Z_Y6JFHHHzP-8LHcwZOfPAGgNcYlRhX_P3nu7bkqKRlRZq6qAjDZYVQ8wzMMBK8oBSTEzBDqKoKWvPvp-AspQeEMCENeQFOcUMYwbSegXhlvMlOw3lKQTuVXfAwWJhXBs59dhsXVQ9vTcrR6f3wUukcIlzctl_or5_w0eUVvB4H5WE7DKMPnbFOO-P1Ft65OCa42K4NxLD11uwbXoLnVvXJvDqe5-Db5afFxXVx8_WqvZjfFJoQngsqkDIIaWq0rRgTii0Z1Z1SqBNGI2FrzbhW1DaCcoHVsiO8Q5VlXFnSMVWfg4-H3vW4HEynjc_TLnId3aDiVgbl5N8T71byPmwkrgWtGzEVvDsWxPBjnL5ADi5p0_fKmzAmiQWva07pBL49gipp1duovHbpz02YUYwZaiaOHTgdQ0rR2CcEyZ1XOXmVHEkqd17lzqvceZ2SH_5Japf3sqaXu_4_8m8O-ZW7Xz26aKRKg3zYuCe6_g1_lrjW |
CitedBy_id | crossref_primary_10_1016_j_micinf_2010_05_004 crossref_primary_10_1016_j_micpath_2021_105326 crossref_primary_10_1186_1742_4690_3_54 crossref_primary_10_3389_fimmu_2017_01616 crossref_primary_10_1371_journal_ppat_1000738 crossref_primary_10_1016_j_vaccine_2014_01_057 crossref_primary_10_3389_fgene_2022_861355 crossref_primary_10_1128_JVI_03603_13 crossref_primary_10_1097_QAD_0b013e328331567a crossref_primary_10_2217_fvl_11_134 crossref_primary_10_3389_fimmu_2018_02876 crossref_primary_10_1371_journal_ppat_1003577 crossref_primary_10_1097_QAI_0b013e318205a59b crossref_primary_10_1371_journal_pone_0002747 crossref_primary_10_1089_aid_2012_0369 crossref_primary_10_1007_s00251_007_0217_7 crossref_primary_10_1371_journal_ppat_0040018 crossref_primary_10_1007_s00251_009_0358_y crossref_primary_10_1016_j_tube_2011_08_004 crossref_primary_10_1007_s12026_016_8810_1 crossref_primary_10_1186_1475_2875_13_236 crossref_primary_10_1016_j_smim_2013_04_007 crossref_primary_10_1073_pnas_0601373103 crossref_primary_10_1016_j_virol_2006_06_031 crossref_primary_10_3390_v13020320 crossref_primary_10_1097_QAD_0000000000000812 crossref_primary_10_1111_j_1365_2796_2008_02041_x crossref_primary_10_1128_JVI_02978_14 crossref_primary_10_1007_s00439_009_0763_1 crossref_primary_10_1038_srep45214 crossref_primary_10_1089_aid_2012_0039 crossref_primary_10_1099_vir_0_050252_0 crossref_primary_10_1016_S2222_1808_16_61145_3 crossref_primary_10_1371_journal_pbio_1000462 crossref_primary_10_1146_annurev_genet_120116_023425 crossref_primary_10_1097_COH_0b013e3282f7cda4 crossref_primary_10_1155_2020_6702169 crossref_primary_10_1371_journal_ppat_1009017 crossref_primary_10_1073_pnas_0605838103 crossref_primary_10_2217_17469600_2_2_167 crossref_primary_10_1007_s11908_007_0013_4 crossref_primary_10_1007_s00439_010_0884_6 crossref_primary_10_1089_aid_2010_0367 crossref_primary_10_1371_journal_pone_0029454 crossref_primary_10_1086_590431 crossref_primary_10_1128_JVI_00688_06 crossref_primary_10_1016_j_tim_2008_09_003 crossref_primary_10_1097_QAD_0b013e32835ab1f2 crossref_primary_10_1097_QAD_0b013e328330b489 crossref_primary_10_1128_JVI_01828_07 crossref_primary_10_1186_1742_4690_10_85 crossref_primary_10_1002_jgm_3004 crossref_primary_10_1002_jmv_26423 crossref_primary_10_1097_QAD_0b013e3282effa87 crossref_primary_10_4103_ijmm_IJMM_20_109 crossref_primary_10_1097_QAD_0b013e32831fb540 crossref_primary_10_1186_1742_4690_3_81 crossref_primary_10_2217_17469600_1_4_399 crossref_primary_10_1097_QAD_0b013e32833b5256 crossref_primary_10_1586_eci_13_16 crossref_primary_10_1371_journal_pone_0084917 crossref_primary_10_1128_JVI_01810_10 crossref_primary_10_1089_aid_2015_0067 crossref_primary_10_1016_j_tig_2010_01_002 crossref_primary_10_1089_aid_2007_0256 crossref_primary_10_1128_JVI_01313_13 crossref_primary_10_1016_S0929_6646_11_60053_3 crossref_primary_10_1128_JVI_00854_11 crossref_primary_10_1016_j_virol_2009_05_038 crossref_primary_10_1016_j_virol_2013_03_021 crossref_primary_10_1002_rmv_637 crossref_primary_10_3390_v6010243 |
Cites_doi | 10.1038/nm0195-59 10.1128/JVI.78.11.5670-5678.2004 10.1073/pnas.172384599 10.1016/S0092-8674(00)80110-5 10.1128/JVI.79.12.7883-7888.2005 10.1016/S0140-6736(97)09185-X 10.1128/JVI.79.14.8969-8978.2005 10.1093/emboj/20.9.2140 10.1128/JVI.73.12.10020-10028.1999 10.7326/0003-4819-128-8-199804150-00001 10.7326/0003-4819-125-4-199608150-00001 10.1086/375140 10.1073/pnas.212400099 10.1038/nature01709 10.4269/ajtmh.1999.61.420 10.1073/pnas.0402361101 10.1006/meth.1997.0487 10.1097/00002030-200307250-00002 10.1038/ng934 10.1073/pnas.0409853102 10.1128/JVI.78.11.6005-6012.2004 10.1073/pnas.200286297 10.1101/gr.8.3.195 10.1038/nature02343 10.1128/JVI.79.7.3930-3937.2005 10.1016/j.cub.2004.12.042 10.1101/gr.8.3.186 10.1128/JVI.79.5.3139-3145.2005 10.1128/JVI.75.17.7944-7955.2001 10.1101/gr.8.3.175 10.1086/314632 10.1128/jvi.71.6.4284-4295.1997 10.1128/JVI.74.21.10074-10080.2000 10.1073/pnas.96.3.1030 10.1086/314556 10.1128/JVI.78.11.6073-6076.2004 10.4049/jimmunol.162.11.6942 10.1093/emboj/cdg042 10.1073/pnas.162299499 10.1073/pnas.0402474101 10.1038/nature00939 10.1073/pnas.0402876101 10.1093/biostatistics/4.4.513 10.1038/nm946 10.1086/343811 10.1056/NEJM199501263320401 10.1128/jvi.64.10.4735-4742.1990 10.1073/pnas.0403364101 10.1016/S0140-6736(95)12269-2 10.1128/JVI.78.20.11070-11076.2004 |
ContentType | Journal Article |
Copyright | 2006 INIST-CNRS Copyright © 2006, American Society for Microbiology 2006 |
Copyright_xml | – notice: 2006 INIST-CNRS – notice: Copyright © 2006, American Society for Microbiology 2006 |
DBID | AAYXX CITATION IQODW 7T5 7T7 7U9 8FD C1K FR3 H94 P64 RC3 5PM |
DOI | 10.1128/JVI.80.5.2463-2471.2006 |
DatabaseName | CrossRef Pascal-Francis Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts Genetics Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Genetics Abstracts Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Genetics Abstracts CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 2471 |
ExternalDocumentID | PMC1395369 17511706 10_1128_JVI_80_5_2463_2471_2006 jvi_80_5_2463 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAFWJ AAGFI AAYJJ AAYXX ABPPZ ACGFO ACNCT ADBBV ADXHL AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 D0S DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ZXP ~02 ~KM IQODW 7T5 7T7 7U9 8FD C1K FR3 H94 P64 RC3 5PM |
ID | FETCH-LOGICAL-c448t-590ae00c5ecf2779a7b75cdaa0d9ec09f3c78ca5f695891abd48d02f78af4d7a3 |
ISSN | 0022-538X |
IngestDate | Thu Aug 21 18:28:14 EDT 2025 Thu Jul 10 22:15:59 EDT 2025 Mon Jul 21 09:15:41 EDT 2025 Tue Jul 01 00:56:59 EDT 2025 Thu Apr 24 22:53:14 EDT 2025 Wed May 18 15:32:09 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Immunopathology Microbiology HIV-1 virus Retroviridae AIDS Immune deficiency Lentivirus Virology Infection Virus Viral disease Antiviral Human immunodeficiency virus |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c448t-590ae00c5ecf2779a7b75cdaa0d9ec09f3c78ca5f695891abd48d02f78af4d7a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Corresponding author. Mailing address: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, D3-100, Seattle, WA 98109-1024. Phone: (206) 667-6704. Fax: (206) 667-4411. E-mail: jmcelrat@fhcrc.org. |
OpenAccessLink | https://jvi.asm.org/content/jvi/80/5/2463.full.pdf |
PMID | 16474153 |
PQID | 19833855 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | pascalfrancis_primary_17511706 proquest_miscellaneous_19833855 highwire_asm_jvi_80_5_2463 crossref_primary_10_1128_JVI_80_5_2463_2471_2006 crossref_citationtrail_10_1128_JVI_80_5_2463_2471_2006 pubmedcentral_primary_oai_pubmedcentral_nih_gov_1395369 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-03-01 |
PublicationDateYYYYMMDD | 2006-03-01 |
PublicationDate_xml | – month: 03 year: 2006 text: 2006-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC |
PublicationTitle | Journal of Virology |
PublicationYear | 2006 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_28_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 (e_1_3_2_39_2) 2000; 132 e_1_3_2_24_2 e_1_3_2_47_2 (e_1_3_2_14_2) 2000; 2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 (e_1_3_2_41_2) 2005; 16 e_1_3_2_54_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_35_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 (e_1_3_2_20_2) 1999; 162 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_2_2 (e_1_3_2_49_2) 1992 |
References_xml | – ident: e_1_3_2_38_2 doi: 10.1038/nm0195-59 – ident: e_1_3_2_51_2 doi: 10.1128/JVI.78.11.5670-5678.2004 – ident: e_1_3_2_5_2 doi: 10.1073/pnas.172384599 – ident: e_1_3_2_24_2 doi: 10.1016/S0092-8674(00)80110-5 – ident: e_1_3_2_4_2 doi: 10.1128/JVI.79.12.7883-7888.2005 – ident: e_1_3_2_36_2 doi: 10.1016/S0140-6736(97)09185-X – volume: 132 start-page: 365 year: 2000 ident: e_1_3_2_39_2 publication-title: Methods Mol. Biol. – ident: e_1_3_2_34_2 doi: 10.1128/JVI.79.14.8969-8978.2005 – ident: e_1_3_2_37_2 doi: 10.1093/emboj/20.9.2140 – ident: e_1_3_2_21_2 doi: 10.1128/JVI.73.12.10020-10028.1999 – ident: e_1_3_2_43_2 doi: 10.7326/0003-4819-128-8-199804150-00001 – ident: e_1_3_2_42_2 doi: 10.7326/0003-4819-125-4-199608150-00001 – ident: e_1_3_2_54_2 doi: 10.1086/375140 – ident: e_1_3_2_30_2 doi: 10.1073/pnas.212400099 – ident: e_1_3_2_26_2 doi: 10.1038/nature01709 – ident: e_1_3_2_12_2 doi: 10.4269/ajtmh.1999.61.420 – ident: e_1_3_2_19_2 doi: 10.1073/pnas.0402361101 – ident: e_1_3_2_3_2 doi: 10.1006/meth.1997.0487 – ident: e_1_3_2_29_2 doi: 10.1097/00002030-200307250-00002 – ident: e_1_3_2_28_2 doi: 10.1038/ng934 – ident: e_1_3_2_40_2 doi: 10.1073/pnas.0409853102 – ident: e_1_3_2_18_2 doi: 10.1128/JVI.78.11.6005-6012.2004 – ident: e_1_3_2_50_2 doi: 10.1073/pnas.200286297 – start-page: 7.22.1 year: 1992 ident: e_1_3_2_49_2 publication-title: Current protocols in immunology – ident: e_1_3_2_16_2 doi: 10.1101/gr.8.3.195 – ident: e_1_3_2_47_2 doi: 10.1038/nature02343 – volume: 2 start-page: 532 year: 2000 ident: e_1_3_2_14_2 publication-title: Rev. Immunogenet. – ident: e_1_3_2_45_2 doi: 10.1128/JVI.79.7.3930-3937.2005 – ident: e_1_3_2_53_2 doi: 10.1016/j.cub.2004.12.042 – ident: e_1_3_2_10_2 doi: 10.1101/gr.8.3.186 – ident: e_1_3_2_48_2 doi: 10.1128/JVI.79.5.3139-3145.2005 – ident: e_1_3_2_31_2 doi: 10.1128/JVI.75.17.7944-7955.2001 – ident: e_1_3_2_11_2 doi: 10.1101/gr.8.3.175 – ident: e_1_3_2_15_2 doi: 10.1086/314632 – ident: e_1_3_2_25_2 doi: 10.1128/jvi.71.6.4284-4295.1997 – ident: e_1_3_2_32_2 doi: 10.1128/JVI.74.21.10074-10080.2000 – ident: e_1_3_2_46_2 doi: 10.1073/pnas.96.3.1030 – ident: e_1_3_2_6_2 doi: 10.1086/314556 – ident: e_1_3_2_55_2 doi: 10.1128/JVI.78.11.6073-6076.2004 – volume: 162 start-page: 6942 year: 1999 ident: e_1_3_2_20_2 publication-title: J. Immunol. doi: 10.4049/jimmunol.162.11.6942 – ident: e_1_3_2_17_2 doi: 10.1093/emboj/cdg042 – ident: e_1_3_2_9_2 doi: 10.1073/pnas.162299499 – ident: e_1_3_2_22_2 doi: 10.1073/pnas.0402474101 – ident: e_1_3_2_44_2 doi: 10.1038/nature00939 – ident: e_1_3_2_52_2 doi: 10.1073/pnas.0402876101 – ident: e_1_3_2_23_2 doi: 10.1093/biostatistics/4.4.513 – ident: e_1_3_2_27_2 doi: 10.1038/nm946 – ident: e_1_3_2_33_2 doi: 10.1086/343811 – volume: 16 start-page: 95 year: 2005 ident: e_1_3_2_41_2 publication-title: Curr. Biol. – ident: e_1_3_2_8_2 doi: 10.1056/NEJM199501263320401 – ident: e_1_3_2_7_2 doi: 10.1128/jvi.64.10.4735-4742.1990 – ident: e_1_3_2_35_2 doi: 10.1073/pnas.0403364101 – ident: e_1_3_2_13_2 doi: 10.1016/S0140-6736(95)12269-2 – ident: e_1_3_2_2_2 doi: 10.1128/JVI.78.20.11070-11076.2004 |
SSID | ssj0014464 |
Score | 2.188423 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... The innate antiviral factor TRIM5α restricts the replication of some retroviruses through its interaction with the viral capsid protein, leading to abortive... The innate antiviral factor TRIM5 alpha restricts the replication of some retroviruses through its interaction with the viral capsid protein, leading to... |
SourceID | pubmedcentral proquest pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2463 |
SubjectTerms | Biological and medical sciences Fundamental and applied biological sciences. Psychology Genetic Diversity and Evolution Human immunodeficiency virus 1 Human viral diseases Infectious diseases Medical sciences Microbiology Miscellaneous Retrovirus Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Virology |
Title | Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection |
URI | http://jvi.asm.org/content/80/5/2463.abstract https://www.proquest.com/docview/19833855 https://pubmed.ncbi.nlm.nih.gov/PMC1395369 |
Volume | 80 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEBIviKvogOEH9lSl5ObEeRyl0zoYD6Ob9ha5ia11WpOpbSaNf8Uf4Z1_wzl2roVxe4mqNLYcny8-Fx9_h5A3oUo8XylhccG45SuXWTyV4PM4ERMyFEE601m-n4KDE__wjJ31et9bWUvFejZMvvzyXMn_SBXugVzxlOw_SLbuFG7Ab5AvXEHCcP0rGSNnNBKutua42vPfy7AsxFJT52NpDlMRfF9X1xlMjydHbHc03n3nmECsCeVP8KxInkokldAnMk_ny2I1QFd14MBKYtK2slvsWXi4E6If68jJaIgl7uXlotnufy-vYSgf5xjKQNPTOs5XIsuVqqM954U-fPW5kPBYE5q9kdngtNiMU3idnI9qA6qdjXo0b9im2qs0OsieLjkMOsoszMh7itZde-U2NaBKhLL2MuybVfNn_eDimYfD08mQ20M2xOcsF_Sz3oNqtwBBXy00bJBwDawcr1GYVZLAhh6tsxsvrucxt2MWY_d3yF0XPBjt7U8-1Btc4IX7FZE9vmqZegjje3vL6JDethxK14aqeK0xrVes4MtWpiRLx2fqZvy2TKjpQ_KgxArdM0B-RHoye0zumWqoN0_IsoQzbcGZ5ooCnGkNZ9qCMzVwphrO375ShDLVUKabUKYayhShTB1aQ_kpOdkfT0cHVlkSxEp8n68tFtlC2nbCZKJgWiMRzkKWpELYaSQTO1JeEvJEMBVEWC5TzFKfp7arQi6Un4bCe0a2sjyTzwmFyZWOtKVjKx8V2SyNkDgJVKDyweyXfRJUkxwnJV8-lm25jLXf7PIYBNXIOUZBYVHXoE_suuGVoYz5c5PtSoqxWC3iDoL6ZKcj16bTkGHdKGj9uhJ0DMoBd_xEJvNiFTsR9zzOWJ-EHfnXXSC5fPefbH6uSebBM2ReEG3_bmQvyP3mS39JttbLQr4CG30929Fo_wH2EeiI |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+Association+of+the+Antiviral+Restriction+Factor+TRIM5%CE%B1+with+Human+Immunodeficiency+Virus+Type+1+Infection&rft.jtitle=Journal+of+Virology&rft.au=Emily+C.+Speelmon&rft.au=Devon+Livingston-Rosanoff&rft.au=Shuying+Sue+Li&rft.au=Quyen+Vu&rft.date=2006-03-01&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=80&rft.issue=5&rft.spage=2463&rft_id=info:doi/10.1128%2FJVI.80.5.2463-2471.2006&rft_id=info%3Apmid%2F16474153&rft.externalDBID=n%2Fa&rft.externalDocID=jvi_80_5_2463 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |